Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.23.1
Equity (Tables)
 9 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of black-scholes option pricing model with weighted average assumptions
    Nine Months
Ended
March 31,
2023		  
Exercise price   $ 2.83 – 4.23  
Expected term (years)     4.00 - 4.75  
Volatility     67 – 70 %
Risk-free interest rate     3.77 – 4.59 %
Dividend yield     0 %
Weighted Average Grant Date Fair Value of Options granted during the period   $ 1.96  

 
Schedule of compensation expense related to our stock-based awards
    Three Months Ended
March 31,		     Nine months ended
March 31,		  
    2023     2022     2023     2022  
Research and Development   $ 1,120     $ 1,327     $ 3,171     $ 4,275  
General and Administrative     2,090       1,179       4,283       3,479  
Total   $ 3,210     $ 2,506     $ 7,454     $ 7,754  

 
Schedule of unrecognized stock-based compensation expense and weighted-average years
    As of March 31, 2023  
    Unrecognized
stock-based
compensation		     Weighted-
average years
to be recognized		  
Options   $ 2,225       1.97  
Restricted stock units   $ 11,725       2.14